Barbara Claire Tilley
#164,183
Most Influential Person Now
Barbara Claire Tilley's AcademicInfluence.com Rankings
Barbara Claire Tilleybiology Degrees
Biology
#13202
World Rank
#16734
Historical Rank
Neuroscience
#2270
World Rank
#2331
Historical Rank
Download Badge
Biology
Why Is Barbara Claire Tilley Influential?
(Suggest an Edit or Addition)Barbara Claire Tilley's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995) (8951)
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results (2008) (4378)
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials (2004) (2577)
- Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials (2010) (1958)
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (2014) (1828)
- Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. (2015) (1685)
- Improved Reliability of the NIH Stroke Scale Using Video Training (1994) (1117)
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan (2007) (1068)
- Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. (1999) (887)
- Effects of tissue plasminogen activator for acute ischemic stroke at one year (1999) (555)
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale (2013) (534)
- Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial (2002) (496)
- Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. (2004) (437)
- Early stroke treatment associated with better outcome The NINDS rt-PA Stroke Study (2000) (398)
- Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. (2001) (375)
- Early stroke treatment associated with better outcome: the ninds rt-pa stroke study (2000) (371)
- Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. (2014) (348)
- Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke (1998) (314)
- Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. (2003) (310)
- Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. (1999) (280)
- Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1997) (258)
- Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study (2006) (249)
- Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. (1996) (239)
- Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations (2010) (225)
- Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. (1999) (225)
- A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease (2006) (224)
- Hypertension and its treatment in the NINDS rt-PA Stroke Trial. (1998) (221)
- Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region (1994) (217)
- A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease (2007) (204)
- Predicting prognosis after stroke (2000) (198)
- A comparison of pregnancy history recall and medical records. Implications for retrospective studies. (1985) (195)
- Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. (2015) (178)
- Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (2012) (164)
- Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. (1997) (164)
- Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer (1985) (163)
- Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. (1980) (156)
- Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society‐unified Parkinson's disease rating scale scores (2012) (140)
- The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. (1990) (134)
- Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial (2000) (131)
- Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. (2014) (127)
- Acculturation and Diabetes among Hispanics: Evidence from the 1999–2002 National Health and Nutrition Examination Survey (2006) (125)
- The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. (2005) (116)
- Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. (2013) (116)
- Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. (1997) (114)
- Vaginal Epithelial Changes in Young Women Enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project (1979) (111)
- Mediating Factors in Dietary Change: Understanding the Impact of a Worksite Nutrition Intervention (2000) (106)
- Marital status, delay in seeking treatment and survival from breast cancer. (1986) (104)
- Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (2013) (103)
- Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? (2002) (103)
- Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients (2017) (101)
- Social support among African-American adults with diabetes, Part 2: A review. (1998) (91)
- Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience (2005) (91)
- Quasi-likelihood estimation for relative risk regression models. (2005) (88)
- Comparison of Laboratory Test Frequency and Test Results Between African-Americans and Caucasians With Diabetes: Opportunity for Improvement: Findings from a large urban health maintenance organization (1997) (86)
- Nutrition intervention for high-risk auto workers: results of the Next Step Trial. (1999) (85)
- Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. (2005) (84)
- Racial variation in clinical and immunological manifestations of systemic sclerosis. (2006) (81)
- Risk factors for major salivary gland carcinoma. A case‐comparison study (1984) (81)
- Nonprescribed Antimicrobial Drugs in Latino Community, South Carolina (2005) (78)
- Optimizing the ongoing search for new treatments for Parkinson disease (2006) (77)
- Psychosocial correlates of healthful diets among male auto workers. (1998) (77)
- Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. (1978) (77)
- Increased Incidence of Cervical and Vaginal Dysplasia in 3,980 Diethylstilbestrol-Exposed Young Women: Experience of the National Collaborative Diethylstilbestrol Adenosis Project (1984) (77)
- A coronary heart disease risk score based on patient-reported information. (2007) (77)
- The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. (1999) (76)
- Pathologic Findings in Young Women Enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project (1979) (75)
- Intention to screen for colorectal cancer among white male employees. (1998) (74)
- Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial (2015) (73)
- The cost and effectiveness of an education program for adults who have asthma (1991) (72)
- A responsive outcome for Parkinson's disease neuroprotection futility studies (2005) (71)
- Racial differences in emergency department use persist despite allergist visits and prescriptions filled for antiinflammatory medications. (1998) (69)
- Fall frequency and risk assessment in early Parkinson's disease. (2012) (67)
- Development of a Measure to Assess Patient Trust in Medical Researchers (2006) (67)
- Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. (2014) (65)
- Differences in MDS‐UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration (2016) (63)
- Correlates and Predictors of Colorectal Cancer Screening among Male Automotive Workers (2007) (62)
- Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer. (2001) (62)
- A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial (1997) (60)
- Nurses' perceptions: issues that arise in caring for patients with diabetes. (1999) (58)
- Intention to be screened over time for colorectal cancer in male automotive workers. (2003) (57)
- The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. (2013) (57)
- Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke (2006) (56)
- Minority enrollment in Parkinson's disease clinical trials. (2009) (53)
- Benefits of stroke treatment delivered using a mobile stroke unit trial (2018) (52)
- Applying a Phase II Futility Study Design to Therapeutic Stroke Trials (2005) (52)
- Adjusting O'Brien's Test to Control Type I Error for the Generalized Nonparametric Behrens–Fisher Problem (2005) (51)
- Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke (2001) (50)
- An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. (2014) (48)
- HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. (1996) (47)
- Self‐reported adherence versus pill count in Parkinson's disease: The NET‐PD experience (2007) (46)
- Examining the Role of Perceived Susceptibility on Colorectal Cancer Screening Intention and Behavior (2010) (45)
- Pioglitazone in early Parkinson's disease (2015) (45)
- Nonprescribed Antimicrobial Drugs in Latino Community (2005) (44)
- Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. (2014) (44)
- Recruitment of African Americans with Type 2 Diabetes to a Randomized Controlled Trial Using Three Sources (2002) (43)
- Erratum: Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke (Stroke (August 2003) 34:8 (1156-1162)) (2003) (41)
- Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step Trial. (1997) (41)
- Retention of Under-represented Minorities in Drug Abuse Treatment Studies (2009) (41)
- Recruiting older African American men to a cancer screening trial (the AAMEN Project). (2003) (40)
- Health outcomes among African American and Caucasian adults following a randomized trial of an asthma education program. (1997) (40)
- Social support among African-American adults with diabetes. Part 1: Theoretical framework. (1998) (40)
- The incidence of ARDS and associated mortality in severe TBI using the Berlin definition (2016) (39)
- Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t‐PA stroke trial (2001) (39)
- Two Pharmacy Interventions to Improve Refill Persistence for Chronic Disease Medications: A Randomized, Controlled Trial (2009) (38)
- Age-related changes in glomerular volume and hydroxyproline content in rat and human. (1992) (38)
- Effect of Hemoglobin Transfusion Threshold on Cerebral Hemodynamics and Oxygenation. (2015) (36)
- An empowerment-centered, church-based asthma education program for African American adults. (1996) (36)
- Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial. (2019) (36)
- Factors influencing physician referrals of patients to clinical trials. (2008) (35)
- Official Japanese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale: Validation Against the Original English Version (2014) (35)
- Caffeine and Progression of Parkinson Disease (2008) (33)
- Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach (2018) (32)
- Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events: The PICSS-APASS Study (2009) (32)
- Handling missing values in the MDS‐UPDRS (2015) (32)
- The Health Education for Lupus Study: A Randomized Controlled Cognitive-Behavioral Intervention Targeting Psychosocial Adjustment and Quality of Life in Adolescent Females With Systemic Lupus Erythematosus (2012) (32)
- Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center (2016) (32)
- Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. (1997) (31)
- Antiphospholipid Antibodies and Risk for Recurrent Vascular Events—Reply (2004) (31)
- Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. (2005) (30)
- A pilot study of health education via a nurse-run telephone self-management programme for elderly people with osteoarthritis (2004) (30)
- Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. (2005) (29)
- Race, education, and knowledge of bone marrow registry: indicators of willingness to donate bone marrow among African Americans and Caucasians. (2004) (29)
- Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. (2009) (29)
- Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. (1999) (28)
- Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis (2013) (28)
- Non-linearity of Parkinson’s disease progression: implications for sample size calculations in clinical trials (2005) (28)
- Using global statistical tests in long‐term Parkinson's disease clinical trials (2009) (27)
- IPMDS‐Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS‐UPDRS and UDysRS (2014) (27)
- A comparison of asthma-related healthcare use between African-Americans and Caucasians belonging to a health maintenance organization (HMO). (1999) (27)
- Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study (2016) (27)
- Risk of colorectal cancer among automotive pattern and model makers. (1990) (27)
- Breast cancer in DES-exposed mothers: absence of association. (1980) (26)
- Cross‐Cultural Differences of the Non‐Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale (2017) (25)
- A randomized recruitment intervention trial in Parkinson’s disease to increase participant diversity: early stopping for lack of efficacy (2012) (25)
- Factor Analysis of the Repeatable Battery for the Assessment of Neuropsychological Status (2008) (25)
- Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio (2015) (25)
- Mentoring in community-based participatory research: the RCMAR experience. (2007) (24)
- Recurrent Femoral Anastomotic Aneurysms: A 30‐Year Experience (1988) (24)
- Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine (2015) (23)
- Application of Beta Regression to Analyze Ischemic Stroke Volume in NINDS rt-PA Clinical Trials (2011) (23)
- Repeatable battery for assessment of neuropsychological status in early Parkinson's disease (2009) (22)
- Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. (1997) (22)
- Design of a cluster-randomized minority recruitment trial: RECRUIT (2017) (21)
- An Assessment of Racial Differences in Clinical Practices for Hypertension at Primary Care Sites for Medically Underserved Patients (2004) (21)
- Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. (2017) (20)
- A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. (1997) (20)
- Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings (2017) (18)
- Screening Potential Therapies: Lessons Learned From New Paradigms Used in Parkinson Disease (2007) (18)
- Caffeine, creatine, GRIN2A and Parkinson's disease progression (2017) (18)
- Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. (1977) (17)
- Place of Death among Hospitalized Patients with Cancer at the End of Life. (2015) (17)
- Minocycline in Rheumatoid Arthritis (1995) (17)
- An efficient multi‐stage, single‐arm Phase II futility design for ALS (2004) (17)
- Cerebral blood flow asymmetry in the detection of extracranial cerebrovascular disease. (1988) (16)
- Autonomic and electrocardiographic findings in Parkinson's disease (2017) (16)
- Perceptions of Diabetes Among Patients in an Urban Health Care System (2002) (16)
- Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury (2015) (15)
- Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA. (1999) (15)
- Pitfalls in the Quest of Neuroprotectants for the Perinatal Brain (2011) (14)
- Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial (2016) (14)
- Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example. (2014) (14)
- Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis. (2003) (14)
- A study of lower extremity amputation rates in older diabetic South Carolinians. (2007) (13)
- Dopamine dysregulation syndrome item from the MDS‐UPDRS (2012) (12)
- Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure and Statistical Analysis of the Primary Outcome in Acute Stroke Trials (2012) (12)
- Identifying and tracing a population at risk: the DESAD Project experience. (1983) (12)
- The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop (2012) (11)
- Stroke Council, American Heart Association Statement for Healthcare Professionals From a Special Writing Group of the Guidelines for the Management of Spontaneous Intracerebral Hemorrhage : A (2006) (11)
- English language skills and diabetes and hypertension among foreign-born South Asian adults in England. (2006) (10)
- Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study—a continuous time Markov chain model with Bayesian approach (2015) (10)
- Aneurysms of the abdominal aorta. (1987) (9)
- Continuous time Markov chain approaches for analyzing transtheoretical models of health behavioral change: A case study and comparison of model estimations (2018) (9)
- Quality of life, medication use, and health care utilization of urban African Americans with asthma treated in emergency departments. (1997) (9)
- Measuring QoL with SF-36 in Older Americans with TBI (2012) (8)
- Communicating with participants during the conduct of multi-center clinical trials (2016) (8)
- Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: Effect of availability of exception from informed consent (2014) (8)
- Gender‐, age‐, and race/ethnicity‐based differential item functioning analysis of the movement disorder society–sponsored revision of the Unified Parkinson's disease rating scale (2016) (7)
- A survey of biostatistical consulting units throughout north america (1995) (7)
- Conduct of Stroke-Related Clinical Trials (2004) (7)
- Validizácia slovenskej verzie Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (2013) (7)
- Exploring willingness of elder Chinese in Houston to participate in clinical research (2016) (6)
- Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience. (2016) (6)
- Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial. (2021) (6)
- Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. (2017) (6)
- Independent Spanish Validation of the Unified Dyskinesia Rating Scale (2014) (6)
- Presurgical serum immunoglobulin concentrations and the prognosis of operable breast cancer in women. (1985) (5)
- Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. (1977) (4)
- Economic analysis of secondary trial data. (2012) (4)
- Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. (2012) (4)
- Religiosity in black and white older Americans (2016) (4)
- Designing clinical trials of treatment for osteoporosis: Recruitment and follow-up (1990) (4)
- Fertility and Outcome of Pregnancy in Women Exposed In Utero to Diethylstilbestrol (1980) (4)
- Global Assessment Variables (2014) (3)
- New version of the UPDRS: Development methods and working document for field testing (2005) (3)
- Lessons from adult stroke trials. (2006) (3)
- Psychosocial Correlates of Healthful Diets among Male Auto 1 (1998) (3)
- Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions (2020) (2)
- Planning the next step. A screening promotion and nutrition intervention trial in the work site. (1994) (2)
- Clinical trials, outcome measures, and response criteria. (2004) (2)
- 60 – Conduct of Stroke-Related Clinical Trials (2011) (2)
- Improving Health Outcomes in Diverse and Vulnerable Populations: Building on the Experience of the Centers for Medical Treatment Effectiveness in Diverse Populations (MEDTEP) (2002) (2)
- Clinimetric testing of the new UPDRS (MDS-UPDRS) vs. original version (2007) (2)
- SUBGROUP ANALYSIS OF CLINICAL TRIALS. REPLY (1991) (2)
- MDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS (P2.052) (2014) (1)
- Secondary analyses in cardiovascular clinical trials - statistical and other considerations. Introduction. (2012) (1)
- Considerations in Deciding When and How to Evaluate Provider Group Interventions (2000) (1)
- Erythropoietin for traumatic brain injury--reply. (2014) (1)
- Measuring Quality of Life with SF-36 in Older Americans with Traumatic Brain Injury. (2012) (1)
- Statistics for the Scale Developer (2012) (1)
- A deming approach to recruiting: The National Institute of Neurological disorders and stroke (NINDS) t-PA stroke trial experience (1992) (1)
- International Observer (2006) (1)
- Analysis of quality control data: Using Fleiss' extension of Cohen's Kappa to test that observer agreement achieves a predetermined standard (1981) (1)
- Composite Endpoints in Clinical Trials (2014) (1)
- Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease (2010) (1)
- Fertility after in utero exposure to DES. [Letter] (1980) (1)
- Abstract B12: Enhancing diversity in clinical trials: Solutions from community members (2010) (1)
- Self-reported smoking and related health behaviors in South Carolina: A geographic analysis of incidence rates of smoking-attributed cancers (2005) (1)
- Apathy , fatigue and quality of life in patients with Parkinson ' s disease (2018) (1)
- A40 Analytical issues for Stroke clinical trials (1996) (1)
- Contents Vol. 40, 2015 (2015) (0)
- A84 Extending intent-to-treat principles to cluster design clinical trials (1996) (0)
- Measuring QoL with SF-36 in Older Americans with TBI (2011) (0)
- Program influences on recruitment and retention of minority participants in addictions treatment research (2004) (0)
- Inclusion of Non–English‐Speaking Participants in Studies of Parkinson's Disease: A Call to Action (2022) (0)
- Medical University of South Carolina — master's and doctoral programs in biostatistics, epidemiology, and biomedical informatics (2001) (0)
- Semiparametric regression modeling of the global percentile outcome. (2022) (0)
- Stroke Trials Outcome Measure and Statistical Analysis of the Primary Outcome in Acute Contemporary Outcome Measures in Acute Stroke Research : Choice of Primary (2012) (0)
- BEST SUBSET SELECTION FOR CATEGORICAL DATA (1981) (0)
- Poster Abstract #14: Recruiting Older Diverse Populations into Studies of Parkinson’s Disease: A Mixed Methods Approach to Development of an Intervention (2007) (0)
- University of Groningen Apathy , fatigue and quality of life in patients with Parkinson ' s disease (2017) (0)
- Edinburgh Research Explorer Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke (2017) (0)
- P1.127 Parkinson's disease subtypes and their relevance to studies of disease-modifying agents (2009) (0)
- The Incidence of Cervical and Vaginal Dysplasia After Exposure to DES-Reply (1986) (0)
- Emberson, J. et al. (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data (2014) (0)
- Using Administrative Data and a Diagnosis Clustering Program to Assess Healthcare Needs of African Americans (1996) (0)
- Handling Missing Values in the MDS-UPDRS (P1.195) (2015) (0)
- Evidence against the association of breast cancer and DES exposure (1978) (0)
- Assessment of Risks from DES (1981) (0)
- Comment on: Stroke therapy academic industry roundtable II (STAIR-II). Authors' reply (2002) (0)
- Fatigue in Parkinson's Disease (P06.052) (2012) (0)
- 39: TRANSFUSION THRESHOLD FOR PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY (2013) (0)
- Vertebral fracture as an end-point for clinical trials in osteoporosis: The reliability of digitizing techniques for vertebral area measurements (1989) (0)
- Abstract A39: Enhancing diversity in clinical trials: Solutions from community members (2010) (0)
- Phase II futility study Chance of calling an effective treatment ineffective Chance of failing to identify an ineffective treatment Traditional phase III superiority trial Chance of calling an ineffective treatment effective Chance of missing an effective treatment Palesch (2005) (0)
- Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 (2004) (0)
- Society for Clinical Trials (2006) (0)
- 8 Ethnic differences in biologic factors related to childhood asthma (1996) (0)
- The Journal of Rheumatology with systemic sclerosis. Demographic and clinical factors associated with in-hospital death among patients (2005) (0)
- Cost‐effectiveness evaluation of the PROPPR trial transfusion protocols (2020) (0)
- 48P Development of a drug accountability system for a national institutes of health sponsored trial (1994) (0)
- New version of the UPDRS (MDS-UPDRS): Factor analysis (2008) (0)
- 60A Global outcome tests for rheumatoid arthritis trials (1994) (0)
- Trust in Medical Researchers Scale (2019) (0)
- 17 Is karyotype an independent prognostic indicator in bladder cancer (1992) (0)
- P33 Recruitment strategies in rheumatoid arthritis (RA) clinical trials (CT): The mira experience (1993) (0)
- ·P-50 Outcome measurements in clinical trials for stroke patients (1990) (0)
- Another look at minocycline. (1996) (0)
- Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 (2004) (0)
- Abstracts from the ASENT 2007 Annual Meeting March 5–8, 2007 (2007) (0)
- Another look at minocycline (multiple letters) (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Barbara Claire Tilley?
Barbara Claire Tilley is affiliated with the following schools:
